,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['tnbc', 'bcsm', 'breast', 'destiny-breast04']
thoughts on destiny-breast04. thread. we need to diversify clinical trials! 53 of 484 (11%) classified as "other". an audience &amp; dr. modi touched on this issue. tnbc among black women &amp; they need to be seen in these studies. #asco22 #bcsm #healthequity 
Mother of Warlords & Slayer of Cancers|Brst/Gyn #radonc @WeillCornell @nyphospital @nypbrooklyn | #globaloncology | #globalhealth|#MedEd|#gyncsm|#bcsm????????